Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs Best Buy Co Inc (BBY) Price & Performance

Amylx Pharmaceuticals IncTrade
Best Buy Co IncTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Best Buy Co Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Best Buy Co Inc trades at $84 (market cap $17.55B). The key difference: Best Buy Co Inc is far larger — about 6.6× Amylx Pharmaceuticals Inc's market cap, and Best Buy Co Inc pays a 4.61% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

AMLXBBY
Market Cap
$2.64B$17.55B
Sector
HealthConsumer Cyclical
52-Week High
$24.19$90.17
52-Week Low
$7.82$55.52
Enterprise Value
$2.39B$19.93B
Dividend Yield
4.61%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About Best Buy Co Inc

With $51.8 billion in fiscal 2022 sales, Best Buy is the largest pure-play consumer electronics retailer in the U.S., with roughly 10.6% share of the aggregate market and north of 40% share of offline sales, per our calculations, CTA industry, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the COVID-19 pandemic, have seen the U.S. e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.

Read more on BBY